HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy.

AuthorsIn-Hyun Park
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 18 Issue 2 Pg. 238-40 (Feb 2010) ISSN: 1525-0024 [Electronic] United States
PMID20125163 (Publication Type: Comment, Journal Article)
Chemical References
  • Dystrophin
Topics
  • Cell- and Tissue-Based Therapy (methods)
  • Chromosomes, Artificial, Human (genetics)
  • Dystrophin (genetics, physiology)
  • Genetic Therapy (methods)
  • Humans
  • Induced Pluripotent Stem Cells (cytology, physiology)
  • Models, Theoretical
  • Muscular Dystrophy, Duchenne (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: